Thread

Claude discovers a novel enzyme system with CRISPR-like repeats

780 points · 805 comments · raahelb

AbstractH24 · 1790194039 · focus · HN ↗
I recently heard Anthropic quietly setup its own bio lab.
That it’s plausible that they’ll move from selling tokens as their primary source of revenue to building frontier models to do cutting edge research, and using the research as their primary source of revenue rather than release the models. Because it’ll be far less of a race to the bottom than commodified tokens used by the general public.
Will be interesting to see how this all unfolds. (No pun intended, but there is a funny one there…)
1. jimmySixDOF · 1790195192 · focus · HN ↗
  apparently big labs are also pitching profit sharing arrangements to biopharma companies in exchange for privileged access to the top internal above-the-api capability models .... repeat this in every industrial vertical and it could turn out that much denied Dario claim may as well have been true for all intents and purposes
  1. finghin · 1790196842 · focus · HN ↗
    Which claim?
    jimmySixDOF · 1790408547 · focus · HN ↗
    Anthropic Left as the Only Private Company in the World? CEO Dario Amodei Pushes Back on Criticism From Critics: 'I Do Not Agree That…'
    <a href="https://finance.yahoo.com/technology/ai/articles/anthropic-left-only-private-company-100049253.html" rel="nofollow">https://finance.yahoo.com/technology/ai/articles/anthropic-l...
  2. AbstractH24 · 1790199959 · focus · HN ↗
    I mean its what universities have done for years haven't they?
    Never really wondered what financial relationship between research hospitals that participate in drug trials and pharma companies is, but now I'm wondering...

Open on Hacker News to reply ↗

Unofficial Hacker News client; not affiliated with Y Combinator.